TP53 and cancer: In 2015, an alternative molecular classification was proposed by the Asian Cancer Research Group, and it included mesenchymal-like tumors, MSI tumors, microsatellite-stable TP53-active (MSS/p53+) and microsatellite-stable TP53-inactive (MSS/p53−) tumors.